For research use only. Not for human or veterinary use. Supplied as a lyophilized powder for laboratory research.
MOTS-c research began in 2015, when scientists reported a short open reading frame (sORF) in the mitochondrial 12S rRNA gene that encodes a 16-amino-acid peptide [1]. MOTS-c stands for “mitochondrial open reading frame of the 12S rRNA-c”. It is one of a small group of mitochondrial-derived peptides, after humanin. In the original mouse work, its primary target organ appeared to be skeletal muscle, and its cellular actions inhibited the folate cycle and de novo purine biosynthesis, leading to AMPK activation [1].
What is MOTS-c? Structure and sequence
| Property | Value |
|---|---|
| Sequence | MRWQEMGYIFYPRKLR (16 residues) (PubChem CID 146675088) |
| Formula / MW | C₁₀₁H₁₅₂N₂₈O₂₂S₂ / ~2174.6 g/mol (PubChem) |
| CAS | 1627580-64-6 (PubChem) |
| Origin | sORF within mitochondrial 12S rRNA [1] |
| Form supplied by MFP | Supplied as a lyophilized powder for laboratory research |
How MOTS-c works in experimental models
The 2015 Cell Metabolism paper reported this mechanism [1]:
- MOTS-c inhibits the folate cycle and the de novo purine biosynthesis tethered to it.
- That leads to activation of AMPK, a central energy-sensing kinase.
- The peptide regulated insulin sensitivity and metabolic homeostasis in mouse models, with skeletal muscle as the apparent primary target.
MOTS-c studies in mouse models
A 2021 Nature Communications study extended the work [2]:
- In mice, MOTS-c regulated nuclear genes, including genes related to metabolism and proteostasis, as well as skeletal muscle metabolism and myoblast adaptation to metabolic stress.
Results in mice do not establish effects in people. Two authors of the 2021 paper disclosed consulting and shareholding ties to CohBar, Inc. [2].
Regulatory status
FDA lists MOTs-C in Category 2 of bulk drug substances nominated for compounding that may present significant safety risks [3]. It is not FDA-approved for any use.
Frequently asked questions
MOTS-c is a 16-amino-acid peptide encoded by a short open reading frame in mitochondrial 12S rRNA [1].
In the original study it inhibited the folate cycle and de novo purine biosynthesis, which led to AMPK activation [1].
Yes. MOTS-c is encoded in mitochondrial DNA, within the 12S rRNA gene [1].
A peptide encoded by a short open reading frame in mitochondrial DNA. Humanin was the first described; MOTS-c was reported in 2015 [1].
Research materials and certificates
- MOTS-c · COA Library
- Related: NAD+ Research · What Are Research Peptides?
References
- Lee C, Zeng J, Drew BG, et al. The mitochondrial-derived peptide MOTS-c promotes metabolic homeostasis and reduces obesity and insulin resistance. Cell Metab. 2015;21(3):443-54. doi:10.1016/j.cmet.2015.02.009. PMID: 25738459
- Reynolds JC, Lai RW, Woodhead JST, et al. MOTS-c is an exercise-induced mitochondrial-encoded regulator of age-dependent physical decline and muscle homeostasis. Nat Commun. 2021;12(1):470. doi:10.1038/s41467-020-20790-0. PMID: 33473109
- U.S. Food and Drug Administration. Certain Bulk Drug Substances for Use in Compounding that May Present Significant Safety Risks (Category 2). Content current as of 04/22/2026. fda.gov
Research-use-only disclaimer: All products from My Freedom Peptides are supplied as a lyophilized powder for laboratory research. They are for research use only and not for human or veterinary use. My Freedom Peptides LLC is a chemical supplier. It is not a 503A compounding pharmacy or a 503B outsourcing facility. These statements have not been evaluated by the Food and Drug Administration. Products are not intended to diagnose, treat, cure, or prevent any disease.
